(Q43172616)

English

Increase in viral yield in eggs and MDCK cells of reassortant H5N1 vaccine candidate viruses caused by insertion of 38 amino acids into the NA stalk

scientific article published on 22 August 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Increase in viral yield in eggs and MDCK cells of reassortant H5N1 vaccine candidate viruses caused by insertion of 38 amino acids into the NA stalk (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

author name string

Wenjun Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Tao Xue

2

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Xiaowei Wu

3

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Pinghu Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Guo Zhao

5

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Daxing Peng

6

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Shunlin Hu

7

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Xiaoquan Wang

8

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Xiaowen Liu

9

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Wenbo Liu

10

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Xiufan Liu

11

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

language of work or name

0 references

publication date

22 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

8032-8041

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry, and humans in China from 2004 to 2009.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Development of a mammalian cell (Vero) derived candidate influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Functional balance between haemagglutinin and neuraminidase in influenza virus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Characterization of temperature sensitive influenza virus mutants defective in neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Large-scale sequence analysis of avian influenza isolates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

The evolution of H5N1 influenza viruses in ducks in southern China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Molecular epidemiological surveys of H5 subtype highly pathogenic avian influenza viruses in poultry in China during 2007-2009.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Alterations of the stalk of the influenza virus neuraminidase: deletions and insertions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Characterization of duck H5N1 influenza viruses with differing pathogenicity in mallard (Anas platyrhynchos) ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

A DNA transfection system for generation of influenza A virus from eight plasmids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Eight-plasmid system for rapid generation of influenza virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Universal primer set for the full-length amplification of all influenza A viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Phylogenetic analysis of eight genes of H9N2 subtype influenza virus: a mainland China strain possessing early isolates' genes that have been circulating

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Characterization of the reconstructed 1918 Spanish influenza pandemic virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Growth determinants for H5N1 influenza vaccine seed viruses in MDCK cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

An 18-amino acid deletion in an influenza neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

A genetically engineered waterfowl influenza virus with a deletion in the stalk of the neuraminidase has increased virulence for chickens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Mechanism by which mutations at his274 alter sensitivity of influenza a virus n1 neuraminidase to oseltamivir carboxylate and zanamivir

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Influenza: its control in persons and populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

The special neuraminidase stalk-motif responsible for increased virulence and pathogenesis of H5N1 influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Enhanced growth of seed viruses for H5N1 influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Human host factors required for influenza virus replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

A host of factors regulating influenza virus replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Extensive accumulation of influenza virus NS1 protein in the nuclei causes effective viral growth in vero cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

Biologic importance of neuraminidase stalk length in influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

based on heuristic

inferred from DOI database lookup

The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

based on heuristic

inferred from DOI database lookup

A single amino acid in the PB2 gene of influenza A virus is a determinant of host range.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.054

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.08.054

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43172616&oldid=1982846576"